On March 10, 2022, Rocket Pharmaceuticals, Inc. announced that Carlos Garcia-Parada tendered his resignation as Chief Financial Officer of the Company, effective March 16, 2022, due to personal reasons. Mr. Garcia-Paradawill continue to serve as an advisor to the Company until March 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.32 USD | -0.61% | -0.47% | -28.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.86% | 1.94B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals, Inc. Announces Resignation of Carlos Garcia-Parada as Chief Financial Officer